SavedAdd your journal

Journals / Journal of Clinical and Experimental Investigations / 2012 / Cilt: 3 - Sayı: 3

Multiple bone metastases detected on 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography in a breast cancer patient: Case report and literature review

Meme kanserli bir hastada 18-Floro-de-oksi-Glukoz pozitron emisyon tomografisinde multiple kemik metastazları: Olgu sunumu ve literatürün gözden geçirilmesi

Buğra KAYA
Oktay SARI
Erhan VAROĞLU
Zeki DOSTBİL
Murat İSMAİLOĞLU
Pages
426–429
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this breast cancer case, 99mTc-MDP bone scintigraphy showed normal findings in regards to skeletal metastasis while 18FFDG- PET/CT, contrast-enhanced CT and MRI revealed multiple metastatic focuses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bone scintigraphy has been widely used to assess skeletal metastasis in patients with breast cancer. 18F-FDGPET/ CT is another imaging modality that has gained previously wide use to determine metastasis based on increased glucose metabolism in malignant cells.
📊
Key Findings & Data:Generally, these two modalities give similar results in evaluation of bone metastasis of breast cancer.
💡
Conclusion & Impact:In this breast cancer case, 99mTc-MDP bone scintigraphy showed normal findings in regards to skeletal metastasis while 18FFDG- PET/CT, contrast-enhanced CT and MRI revealed multiple metastatic focuses.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bone scintigraphy has been widely used to assess skeletal metastasis in patients with breast cancer. 18F-FDGPET/ CT is another imaging modality that has gained previously wide use to determine metastasis based on increased glucose metabolism in malignant cells. Generally, these two modalities give similar results in evaluation of bone metastasis of breast cancer. In this breast cancer case, 99mTc-MDP bone scintigraphy showed normal findings in regards to skeletal metastasis while 18FFDG- PET/CT, contrast-enhanced CT and MRI revealed multiple metastatic focuses.

Özet

Kemik sintigrafisi, meme kanserli hastaların iskelet sistemi metastazlarının değerlendirilmesinde halen yaygın olarak kullanılmaktadır. 18F-FDG-PET/BT, malign hücrelerde artmış glukoz metabolizmasının görüntülenmesi prensibine dayanarak metastazları tespit etmede son yıllarda yaygın kullanım alanı kazanmış diğer bir görüntüleme yöntemidir. Genel olarak, meme kanserinin kemik metastazlarının tespitinde bu iki yöntem benzer sonuçlar vermektedir. Meme kanserli bu olguda 99mTc-MDP kemik sintigrafisi kemik metastazı yönünden normal bulgular göstermesine karşın 18F-FDG-PET/BT, kontrastlı BT ve MRda iskelet sisteminde birçok odakta kemik metastazları tespit edilmiştir.

🔖

Cite This Article

KAYA, B., SARI, O., VAROĞLU, E., DOSTBİL, Z., İSMAİLOĞLU, M. (2022). Multiple bone metastases detected on 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography in a breast cancer patient: Case report and literature review. Journal of Clinical and Experimental Investigations, Cilt: 3 - Sayı: 3, 426–429. https://ajindex.com/articles/561951

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 2001;22(8):875-9
  2. Chen YW, Huang MY, Hsieh JS, Hou MF, Chou SH, Lin CL. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review. Kaohsiung J Med Sci 2007;23(12):639- 46
  3. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55(1):61-6
  4. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004;350(16):1655-64
  5. Liu T, Xu JY, Xu W, Bai YR, Yan WL, Yang HL. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?-a meta-analysis. Clin Oncol (R Coll Radiol) 2011;23(5):350-8
  6. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 2007;36(12):1109-19
  7. Ozülker T, Küçüköz AU, Ozülker F, Ozpaçacı T. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients. Nucl Med Commun 2010;31(6):597-603
  8. Taube T, Elomaa I, Blomqvist C, Beneton MN, Kanis JA. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994;15(2):161-6
  9. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001;27(3):165-76
  10. Min JW, Um SW, Yim JJ, et al. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. J Korean Med Sci 2009;24(2):275-80
  11. Gallowitsch HJ, Kresnik E, Gasser J, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 2003;38(5):250-6
  12. Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology 2005;237(2):627-34
  13. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and tc-99m MDP bone scan to